Literature DB >> 24603779

As drug target reemerges, the question is to block or stimulate it.

Cassandra Willyard.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24603779     DOI: 10.1038/nm0314-222

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  Impact of the AT(2) receptor agonist C21 on blood pressure and beyond.

Authors:  Sébastien Foulquier; U Muscha Steckelings; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

2.  Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.

Authors:  Gerry T M Wagenaar; El Houari Laghmani; Melissa Fidder; Rozemarijn M A Sengers; Yvonne P de Visser; Louwe de Vries; Rick Rink; Anton J M Roks; Gert Folkerts; Frans J Walther
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464

3.  AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression.

Authors:  Pawel Namsolleck; Francesco Boato; Katja Schwengel; Ludovit Paulis; Katherine S Matho; Nathalie Geurts; Christa Thöne-Reineke; Kristin Lucht; Kerstin Seidel; Anders Hallberg; Björn Dahlöf; Thomas Unger; Sven Hendrix; U Muscha Steckelings
Journal:  Neurobiol Dis       Date:  2012-11-19       Impact factor: 5.996

4.  Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons.

Authors:  U Anand; P Facer; Y Yiangou; M Sinisi; M Fox; T McCarthy; C Bountra; Y E Korchev; P Anand
Journal:  Eur J Pain       Date:  2012-12-17       Impact factor: 3.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.